Walter B - Search Results

1

High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.

Blana A, Walter B, Rogenhofer S, Wieland WF. Blana A, et al. Among authors: walter b. Urology. 2004 Feb;63(2):297-300. doi: 10.1016/j.urology.2003.09.020. Urology. 2004. PMID: 14972475 Review.

2

Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery.

Thalmann GN, Markwalder R, Walter B, Studer UE. Thalmann GN, et al. Among authors: walter b. J Urol. 2002 Oct;168(4 Pt 1):1381-5. doi: 10.1016/S0022-5347(05)64454-0. J Urol. 2002. PMID: 12352398

3

Morbidity associated with repeated transrectal high-intensity focused ultrasound treatment of localized prostate cancer.

Blana A, Rogenhofer S, Ganzer R, Wild PJ, Wieland WF, Walter B. Blana A, et al. Among authors: walter b. World J Urol. 2006 Nov;24(5):585-90. doi: 10.1007/s00345-006-0107-x. Epub 2006 Jul 19. World J Urol. 2006. PMID: 16850340

4

Role of the STK15 Phe31Ile polymorphism in renal cell carcinoma.

Hammerschmied CG, Stoehr R, Walter B, Wieland WF, Hartmann A, Blaszyk H, Denzinger S. Hammerschmied CG, et al. Among authors: walter b. Oncol Rep. 2007 Jan;17(1):3-7. Oncol Rep. 2007. PMID: 17143471

5

Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?

Denzinger S, Otto W, Burger M, Hammerschmied C, Junker K, Hartmann A, Wieland WF, Walter B. Denzinger S, et al. Among authors: walter b. World J Surg Oncol. 2007 Feb 5;5:16. doi: 10.1186/1477-7819-5-16. World J Surg Oncol. 2007. PMID: 17280613 Free PMC article.

6

Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.

Dahl E, Wiesmann F, Woenckhaus M, Stoehr R, Wild PJ, Veeck J, Knüchel R, Klopocki E, Sauter G, Simon R, Wieland WF, Walter B, Denzinger S, Hartmann A, Hammerschmied CG. Dahl E, et al. Among authors: walter b. Oncogene. 2007 Aug 16;26(38):5680-91. doi: 10.1038/sj.onc.1210345. Epub 2007 Mar 12. Oncogene. 2007. PMID: 17353908

7

Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study.

Denzinger S, Burger M, Walter B, Knuechel R, Roessler W, Wieland WF, Filbeck T. Denzinger S, et al. Among authors: walter b. Urology. 2007 Apr;69(4):675-9. doi: 10.1016/j.urology.2006.12.023. Urology. 2007. PMID: 17445650 Clinical Trial.

8

PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer.

Ganzer R, Rogenhofer S, Walter B, Lunz JC, Schostak M, Wieland WF, Blana A. Ganzer R, et al. Among authors: walter b. Eur Urol. 2008 Mar;53(3):547-53. doi: 10.1016/j.eururo.2007.07.010. Epub 2007 Jul 17. Eur Urol. 2008. PMID: 17662520

9

First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer.

Blana A, Murat FJ, Walter B, Thuroff S, Wieland WF, Chaussy C, Gelet A. Blana A, et al. Among authors: walter b. Eur Urol. 2008 Jun;53(6):1194-201. doi: 10.1016/j.eururo.2007.10.062. Epub 2007 Nov 5. Eur Urol. 2008. PMID: 17997026

10

Factors predicting for formation of bladder outlet obstruction after high-intensity focused ultrasound in treatment of localized prostate cancer.

Blana A, Hierl J, Rogenhofer S, Lunz JC, Wieland WF, Walter B, Bach T, Ganzer R. Blana A, et al. Among authors: walter b. Urology. 2008 May;71(5):863-7. doi: 10.1016/j.urology.2007.12.076. Epub 2008 Mar 3. Urology. 2008. PMID: 18313119

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

665 results

Search Page